Additional information
White Powder
212316-88-6
ACI-120722
5-4’-({2-Butyl-5-(5-{4’-(2-butyl-4-chloro-5-hydroxymethyl-1H-imidazol-1-yl)methylbiphenyl-2-yl}-1 H-tetrazol-1-yl)methyl-4-chloro- 2 H-imidazol-1-yl}methyl)biphenyl-2-yltetrazol, potassium salt
5-[4’-({2-Butyl-5-[(5-{4’-[(2-butyl-4-chloro-5-hydroxymethyl-1H-imidazol-1-yl)methyl]biphenyl-2-yl}-1 H-tetrazol-1-yl)methyl]-4-chloro- 2 H-imidazol-1-yl}methyl)biphenyl-2-yl]tetrazol, potassium salt
134.4-135.2°C
C44H44Cl2KN12O
865.9
Ambient
2-8°C
N2-Losartanyl-losartan Potassium Salt; [2-Butyl-1-[[2'-[2-[[2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazol-5-yl]methyl]-2H-tetrazol-5-yl]biphenyl-4-yl]methyl]-4-chloro-1H-imidazol-5-yl]methanol Potassium Salt;(Imp.M (EP) as potassoum salt)(2H-dimer-USP)
Angiotensin receptor blocker
![Ethyl (3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethylsulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate](https://staging.analyticachemie.in/wp-content/uploads/1A06130-150x150.png)
![2-sec-butyl-4-{4-[4-(4-methoxyphenyl)piperazin-1-yl]phenyl}-2H-1,2,4-triazol-3(4H)-one](https://staging.analyticachemie.in/wp-content/uploads/1A06380-150x110.png)
![Abiraterone Isopropyl Ether (25 mg) (3-((3S,8R,9S,10R,13S,14S)-3-isopropoxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine; 3beta-Isopropoxy-17-(pyridin-3-yl)androsta-5,16-diene)](https://staging.analyticachemie.in/wp-content/uploads/image-1-150x145.png)
